Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXPAND: 10 GE Xenokidney in ESRD
NCT06878560Phase 2Recruiting
- Sponsor
- United Therapeutics Corporation
- Start
- Oct 2025
- Primary completion
- Oct 2028
- Modality
- Tissue Cells
- Countries
- 1
01
Overview
A Phase 2 trial of UKidney in end stage renal disease (ESRD), sponsored by United Therapeutics Corporation. Started Oct 2025; status: recruiting.
02
Drugs
UKidney
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT06878560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06878560.